The formation of primordial follicles occurs during fetal life yet is critical to the determination of adult female fertility. Prior to this stage, germ cells proliferate, enter meiosis, and associate with somatic cells. Growth and survival factors implicated in these processes include activin A (INHBA), the neurotrophins BDNF and NT4 (NTF5), and MCL1. The prostaglandins have pleiotrophic roles in reproduction, notably in ovulation and implantation, but there are no data regarding roles for prostaglandins in human fetal ovarian development.
O
varian development in the first trimester of pregnancy is characterized by germ cell proliferation. Some germ cells continue to undergo mitosis throughout the second trimester (1), but there is increasing entry into meiosis and changing associations with somatic cells such that ultimately some germ cells form primordial follicles whereas the majority are believed to undergo apoptosis (2) (3) (4) . During this period, a number of germ-cell markers (OCT4, DAZL, VASA) are expressed associated with different stages of germ cell development (5) . Additionally, growth factors including activin A (encoded by INHBA) and the neurotrophins brain-derived neurotrophic factor (BDNF) and NT4 (encoded by NTF5) have been demonstrated previously to be important during fetal ovary development (4, 6 -14) , but there is very limited information regarding their control and interactions.
Prostaglandins (PGs) mediate many important biological processes and are recognized as key molecules in re-productive function (15) , particularly in ovulation and implantation. Involvement in sex determination has been proposed (16) , but roles in early stages of oogenesis or folliculogenesis have not been identified. PGs are produced from arachidonic acid by cyclooxygenase (COX) enzymes and specific terminal prostanoid synthase enzymes. There are two predominant COX enzyme isoforms (COX1 and COX2) (17) . COX1 is constitutively expressed in many cell types, whereas COX2 is induced by factors including cytokines and tumor promoters (17) . COX enzymes convert arachidonic acid to an intermediate PG, PGH 2 , and this is converted to PGE 2 by PGE synthase (PTGES).
Once synthesized, PGs act in an autocrine or paracrine manner through binding to a family of prostanoid-specific G protein-coupled receptors (18) . For PGE 2 , there are four different receptors (EP1-EP4) that have distinct but overlapping tissue distributions and activate different intracellular signaling pathways and gene expression (19) . EP2 and EP4 receptors elevate intracellular cAMP accumulation via G ␣s (20) .
In light of the important roles for PGs in later follicle function, we have investigated whether PG synthetic enzymes and receptors are expressed in the human fetal ovary during the developmental period when oogonia proliferate, enter meiosis, and start to form primordial follicles. We then proceeded to examine whether PGE 2 has any effect on the expression of genes already identified to be important at this stage. We demonstrate that PGE 2 may have important roles in oocyte development and survival during this crucial period when a woman's endowment of eggs for the whole of her reproductive life is determined.
Materials and Methods

Tissue
First-and second-trimester ovaries were obtained after medical termination of pregnancy for social reasons as described previously (7) . Maternal consent was obtained, and the study was approved by the Lothian Research Ethics Committee. Gestation was determined by ultrasound scan and subsequent direct measurement of foot length. The sex of first-trimester ovaries was confirmed by PCR for the male-specific gene SRY. Ovaries were removed and used directly for culture, snap-frozen, and stored at Ϫ80 C or fixed in Bouins solution before processing into paraffin using standard methods. A total of 41 fetal specimens were used in this study.
Immunohistochemistry
Paraffin-embedded second-trimester ovaries were cut into 5-m sections and mounted onto electrostatically charged microscope slides (VWR, Leicestershire, UK). Immunohistochemistry was performed as previously described (21), except where stated. For those antibodies requiring antigen retrieval (EP2, PTGES, COX1, and COX2), the slides were pressure cooked for 5 min in 0.01 M citrate buffer and left to stand for 20 min before cooling in water. Sections were blocked with avidin and then biotin (both from Vector, Peterborough, UK). Primary antibodies were rabbit polyclonal antibodies to EP2 (101750), EP4 (101775), and PTGES (160140) (all from Cayman Chemical Co., Ann Arbor, MI; diluted 1:100, 1:500, and 1:50, respectively), or goat polyclonal antibodies to COX1 (sc-1752) and COX2 (sc-1745) (both from Santa Cruz Biotechnology, Santa Cruz, CA; each diluted 1:50). Secondary antibodies were swine antirabbit biotinylated (E0353), diluted 1:500 (EP2 and EP4); goat antirabbit biotinylated (E0437), diluted 1:500 (PTGES) (both from Dako, Cambridge, UK); or chicken antigoat biotinylated (sc-2984) (Santa Cruz Biotechnology) diluted 1:200 (COX1 and COX2). Primary antibodies were preincubated with the supplied blocking peptide as a negative control. Sections were developed with streptavidin-horseradish peroxidase and 3,3Ј-diaminobenzidine tetrahydrochloride (Dako) and counterstained with hematoxylin. Images were captured using an Olympus Provis microscope (Olympus Optical Co., London, UK) equipped with a Kodak DCS330 camera (Eastman Kodak Co, Rochester, NY).
For dual staining immunofluorescence, antigen retrieval, and peroxidase, avidin/biotin and serum blocks were performed as above. Slides were then sequentially incubated with EP2 antibody diluted 1:4000 in normal goat serum (Diagnostics Scotland, Carluke, UK; 1:4 in PBS containing 5% BSA), goat antirabbit peroxidase IgG H&L Fab fragments (ab7171; Abcam plc, Cambridge, UK), and then the TSA Plus Cy3 System (PerkinElmer Life Sciences, Beaconsfield, Buckinghamshire, UK) diluted 1:50 in substrate with two washes in PBS ϩ 0.05% Tween 20 and PBS between each incubation. After a second antigen retrieval by microwaving in 0.01 M citrate buffer for 4 min, slides were blocked again in normal goat serum/PBS/BSA before adding EP4 antibody diluted 1:1000; goat antirabbit peroxidase IgG H&L Fab fragments diluted 1:500, and then the TSA Plus Fluorescein System (Perkin-Elmer Life Sciences) diluted 1:50 in substrate, again with washes in between. Sections were counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI) (1:1000 in PBS; Sigma, Poole, UK), washed again, and mounted in Permafluor (Beckman Coulter, High Wycombe, UK). Fluorescent images were captured using a LSM510 confocal microscope (Carl Zeiss Ltd., Welwyn Garden City, Hertfordshire, UK).
Culture of fetal ovaries
Human fetal ovaries of 14 -17 wk gestation (n ϭ 6, 3 ϫ 15 wk, 2 ϫ 16 wk, and 1 ϫ 17 wk) were cultured as small explants in cell culture inserts essentially as described previously (10) . For each experiment, both ovaries from a single fetus were dissected cleanly in HBSS (Sigma, Poole, UK), cut into approximately 1-mm cubes, and then distributed equally between the three treatment groups (thus approximately six per treatment). Tissue was cultured in ␣MEM ϩ GlutaMAX with 1X nonessential amino acids (both from Invitrogen, Paisley, UK); 2 mM sodium pyruvate and 3 mg/ml BSA Fraction V (both from Sigma, Poole, UK); and penicillin/streptomycin/amphotericin B (Cambrex Biosciences, Baltimore, MD) for 8 h in the presence of no treatment, 3 g/ml indomethacin (Sigma, Poole, UK) ϩ vehicle (ethanol), or 3 g/ml indomethacin ϩ 100 nM PGE 2 (Sigma). Indomethacin was included to reduce endogenous PG production, thus potentially enhancing the effect of exogenous PGE 2 . Each set of explants was then homogenized in RLT Buffer (QIAGEN, Crawley, UK) containing 0.14 M 2-mercaptoethanol before storage at Ϫ80 C.
RNA extraction and first strand cDNA synthesis
RNA was extracted from RLT lysates of cultured ovary using the RNeasy Micro Kit (QIAGEN) or from frozen uncultured ovaries (dissected clean of mesonephros in the case of first-trimester specimens) using the RNeasy Mini Kit (QIAGEN), both with on-column DNase I digestion according to the manufacturer's protocol. RNA concentration and purity were measured on the NanoDrop 1100 (NanoDrop Products, Wilmington, DE) and first strand cDNA synthesized from 200 ng RNA using Superscript III Reverse Transcriptase Master Mix Ϯ the RT enzyme mix (RTϩ and RTϪ, respectively) according to the manufacturer's recommendations (Invitrogen).
RT-PCR analysis
RT-PCR for COX1, COX2, PTGES, EP2, and EP4 as well as GAPDH (housekeeping gene control) was performed on RTϩ and RTϪ samples of first-and second-trimester human fetal ovary or human endometrial cDNA (as a positive control) using HotStar Taq DNA Polymerase (QIAGEN) and the primers shown in Table 1 . PCRs were incubated at 95 C for 15 min, followed by 35 cycles of 95 C for 30 sec; 60 C for 30 sec; and 72 C for 30 sec, with a final extension step of 72 C for 10 min. PCRs were analyzed by agarose gel electrophoresis ͓2.5% agarose gels, stained with GelRed nucleic acid stain (Cambridge Bioscience Ltd., Cambridge, UK)͔.
Quantitative RT-PCR analysis of gene expression
Quantitative RT-PCR was performed using PowerSYBR Green Master Mix and the ABI7900HTFast system with SDS2.0 software (gestation analysis) or ABI7500 Fast system with SDS1.1 software (cultures; all Applied Biosystems, Warrington, UK) under standard run conditions using the default two-step PCR protocol with dissociation curve analysis. Standard curves for products of each gene transcript (Table 1) were performed using cDNA dilutions (1:5 to 1:10 000) generated from 19-wk human fetal ovary RNA. Then 1:10 dilutions of uncultured or 1:5 dilutions of cultured ovary cDNA were used for quantitative comparisons relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which has previously proved to be a suitable normalization control in the human fetal ovary. Melt curves were analyzed to confirm specific products, and standard curves yielded slopes approaching Ϫ3.324 with R 2 values close to 0.99, allowing quantification using the 2
Ϫ⌬⌬Ct method. For gestational analysis of expression, samples were grouped into three developmental stages: first-trimester tissue (8 -9 wk; germ cell proliferation); early second trimester (14 -16 wk; some initiation of meiosis); later second trimester (17-21 wk; widespread meiosis, follicle formation).
Statistical analysis
RT-PCR data were analyzed by ANOVA with post hoc Bonferroni and linear trend tests (gestation analysis) or paired t tests on log-transformed data comparing PGE 2 ϩ indomethacin treatment to indomethacin-only treatment (as the appropriate 
Results
COX enzymes, PTGES, and PG receptors EP2 and EP4 are expressed in the human fetal ovary
RT-PCR analysis
Expression of the genes required for PGE 2 signaling was investigated by RT-PCR in the human fetal ovary. COX1 (PTGS1), COX2 (PTGS2), PTGES, EP2, and EP4 were initially assayed on 64-d (first trimester), 14-and 18-wk fetal ovary cDNAs. All genes were found to be expressed in all RTϩ cDNA samples (Fig. 1A) , although COX2 was barely detectable in first-trimester ovary.
Quantitative RT-PCR analysis of these genes (Fig. 1B ) demonstrated that COX1 expression remains fairly stable across fetal ovary development with no significant changes. COX2 mRNA levels are very low throughout (below the limit of quantitative detection, data not shown). In contrast, PTGES mRNA levels fell 3-fold (P ϭ 0.002) between first-and early second-trimester ovary before increasing again 2-fold by later gestations (P ϭ 0.008). Differences between the earliest and latest gestations analyzed were not significant. Regarding the receptors, EP2 mRNA did not change significantly across the range of gestations, but EP4 levels rose gradually across development with a statistically significant linear trend (P ϭ 0.03).
Immunohistochemical analysis
We investigated the cellular localization of these same gene products in the fetal ovary by immunohistochemistry. COX1 was strongly expressed in the surface epithelium and in somatic cells intermingling between germ cells (Fig.  2, A-C) . No staining of germ cells was observed. Staining was strongest in the cortex near the surface epithelium, with a reducing gradient of expression in somatic cells among the more mature germ cells located more centrally (Fig.  2, A and B) . Only somatic cells in and around germ cell nests or surrounding follicles were stained: cells within the somatic cell streams showed no expression of COX1. The pattern of COX2 expression was markedly different (Fig. 2D) . Staining was confined to the germ cell compartment (Fig. 2, E and F) . The intensity of staining was variable both between oocyte nests and within nests, with some oocytes having higher levels of COX2 than others (Fig.  2E ). COX2 expression was maintained within the oocytes of primordial follicles (Fig. 2F ) in later-gestation specimens.
To assess whether the fetal ovary can specifically synthesize PGE 2 , we next investigated expression of microsomal PTGES in ovaries where COX activity is clearly present. As with COX2, PTGES was predominantly localized to germ cells and was absent from somatic cell streams (Fig. 2, G-I) , with expression appearing to increase at later gestations.
The presence of the PGE 2 receptors, EP2 and EP4, was also investigated. Clear germ cell expression of EP2 was detected in second-trimester ovary (Fig. 3, A-C) with staining stronger toward the inner cortex and absent from those germ cells at the outermost cortex (Fig. 3C) . Staining of the cell surface of the oocytes was more obvious at 19 wk gestation, both within nests and in primordial follicles (Fig. 3B) . EP4 was also expressed by germ cells (Fig. 3 , D-F) but, in contrast to EP2, expression was strongest in germ cells at the periphery of the ovary with a reducing gradient of expression toward the inner cortex (Fig. 3D) . The differential but overlapping expression of EP2 and EP4 was particularly evident after dual staining immunofluorescence (Fig. 3, G-I) , confirming exclusive expression of EP4 by germ cells most peripherally located and expression of both by some germ cells located away from the peripheral zone. There was no evidence of either EP2 or EP4 in the somatic cells at any gestation.
BDNF, INHBA, and MCL1 gene expression are up-regulated by PGE 2 in cultured ovary
To determine whether exogenous PGE 2 alters germ cell gene expression, organ explants were cultured in the presence or absence of PGE 2 for 8 h (n ϭ 6), and the tissue was immediately lysed for RNA extraction. No significant differences in gene expression of the germ cell markers OCT4, DAZL, or VASA were noted between PGE 2 -treated and appropriate control cultures (Fig. 4, top  panel) . Despite natural variation in expression between specimens that was not gestation related (reflected in the error bars in Fig. 4) , expression of INHBA (activin A) and BDNF showed robust and reproducible increases with PGE 2 treatment. INHBA showed a 2.1 Ϯ 0.51-fold increase (P ϭ 0.04) with PGE 2 (Fig. 4, middle panel) , and BDNF expression rose 1.7 Ϯ 0.16-fold with PGE 2 treatment (P ϭ 0.004). NTF5 expression tended to fall but did not show consistent changes between experiments (Fig. 4,  middle panel) . Expression of the antiapoptotic factor MCL1 (expressed exclusively in germ cells (4)) also showed a significant increase in expression (Fig. 4 , lower panel; P ϭ 0.04) but only of 1.15 Ϯ 0.06-fold. The activin signaling factor SMAD3 mRNA (expressed in somatic cells) was unchanged by PGE 2 (Fig. 4, lower panel) . There were no significant changes in expression of any gene between indomethacin-treated and untreated samples.
Discussion
PGs are well-recognized as essential mediators of several processes in female reproduction, most notably ovulation
FIG. 2. Immunohistochemical localization of COX1 (A-C), COX2 (D-F), and PTGES (G-I) in second-trimester human fetal ovaries. Gestations:
A, B, E, and G, 14 wk; H and I, 17 wk; C, D, and F, 19 wk. Insets show peptide-blocked negative controls. Positive 3,3Ј-diaminobenzidine tetrahydrochloride staining in all panels is brown, and sections are counterstained with hematoxylin. S, Somatic cell (S1, somatic cell within "cord"; S2, somatic cell among germ cells); gc, germ cell; gc*, germ cell staining more intensely for COX2; PF, primordial follicle; se, surface epithelium. Scale bars are all 50 m. and implantation. The data presented here provide evidence that PGs may also have important roles in the development of the ovary, providing a basis for autocrine germ cell PGE 2 signaling as well as paracrine signaling of PGs from somatic granulosa precursor cells to adjacent germ cells. Furthermore, addition of PGE 2 to ovarian tissue in vitro was shown to selectively increase expression of germ cell-expressed genes identified as important regulators of this stage of ovarian development.
The data demonstrate the expression of genes encoding the key enzymes required for the synthesis of PGE 2 , i.e. COX1, COX2, and PTGES, and the mediators of its effects, i.e. its receptors EP2 and EP4. Levels of COX enzyme mRNAs did not change across gestation, indicating that fairly constant levels of precursors are available, but levels of PTGES mRNA were reduced at 14 -16 wk and then rose again from 17 wk. This rise at later gestations also appears to be reflected at the protein level, although a quantitative analysis of the immunohistochemistry was not performed. Levels of EP4 receptor mRNA rose gradually with development, and EP4 was found to be exclusively expressed by germ cells. Whether this reflects an increasing role for this receptor as the ovary develops or simply a relative increase in the number of germ cells that express it is not yet clear, but EP4 continues to be expressed in the more mature, more centrally located germ cells that express EP2. EP2 mRNA levels did not change across the gestational range, yet the EP2 receptor protein is only expressed in more mature germ cells. These changes may reflect multiple roles for PGE 2 as it interacts with different EP receptors as oocytes mature.
The striking differences in distribution of COX1 protein ͓somatic cells, mostly at the periphery of the ovary where germ cells are less mature and express the pluripotency marker OCT4 (5)͔ and COX2 (germ cells, including maturing oocytes within nests and those already enclosed in primordial follicles) indicates a range of functions, which may be mediated by several PGs. In addition to the data on PGE 2 reported here, PGD 2 has been implicated in gonadal development in the mouse, specifically in male sex-specific Sertoli cell specification (22) at the time of sex determination. No previous data on PG function are available in the developing ovary. Although a range of other PGs may derive from the actions of COX1 and COX2, PTGES specifically converts PGH 2 to PGE 2 , and this enzyme was found to be predominantly localized to germ cells. The two receptors for PGE 2 , EP2 and EP4, were also germ cell specific, suggesting an autocrine role for germ cell-derived PGE 2 .
Subsequent studies investigated the regulation of potential target genes that can be activated by PGE 2 . The EP2 and EP4 receptors are found solely on germ cells, so this is where the first changes in gene expression are likely to occur. We therefore assessed expression of the germ cell markers OCT4, DAZL, and VASA whose expression levels are associated with different stages of germ cell development within the fetal ovary (5) . No significant changes were observed that might suggest a general effect on a certain stage of germ cell development. However, the absence of changes in these germ cell genes supports the specificity of the changes in expression of the germ cell growth factor genes, rather than their being nonspecific effects on germ cell survival.
Expression of INHBA mRNA in the human fetal ovary rises during the second trimester from about 17 wk gestation (10). Activin ␤A protein expression is restricted to a proportion of larger oocytes within cell nests that are about to undergo nest breakdown and primordial follicle formation (10) . It is largely believed to act on adjacent somatic cells, based on the localization of its transcription factors phosphorylated SMADs 2 and 3, and may regulate oocyte development through the regulation of kit ligand/c-KIT signaling (7, 23) . PGE 2 increased gene expression of INHBA, thus potentially promoting this transition. PGE 2 has been shown to induce INHBA, as well as INHA, in cultured human granulosa-lutein cells (24) , thus this appears to be a conserved pathway in ovarian function.
BDNF mRNA levels were similarly observed to rise after PGE 2 treatment. PGE 2 and PGD 2 have been shown to be powerful inducers of the neurotrophins NGF and BDNF in mouse astrocyte cultures (25) . As well as their roles in neuronal cells, BDNF and NT4 (NTF5), which bind to and activate the Tropomyosin-related Kinase B receptor, are important signaling molecules in the developing mammalian ovary (6, 8, 9, (11) (12) (13) (14) . However, PGE 2 had no significant effect on NTF5 expression (indeed the trend was toward a decrease in expression), indicating the specificity of the effect on BDNF. BDNF and NTF5 are expressed predominantly in somatic cells, but BDNF is also present in germ cells at later gestations (our unpublished observations). Our results cannot differentiate between changes in the somatic or germ cell compartment; but, given the localization of PGE 2 receptors, the relatively short time-course of the treatment, and the lack of any effect on SMAD3 mRNA, another somatic cell marker, it may be that BDNF mRNA is elevated specifically in germ cells and thus explain why NTF5 expression is not affected.
MCL1 is an antiapoptotic member of the BCL2 family (26) . We have previously demonstrated an increase in expression of the long isoform mRNA during the second trimester and that it is exclusively localized to more mature germ cells including those within primordial follicles (4). We observed a small but significant increase in MCL1 mRNA levels after PGE 2 treatment, suggesting a positive role for PGE 2 in germ cell survival. Because MCL1 expression is also reported to be regulated by activin in other systems (27) , it is possible that the small change detected here is secondary to increased activin expression, which could be explored further in longer-duration cultures.
In conclusion, these data provide novel evidence for roles for PGs, and specifically PGE 2 , in ovarian develop-ment. Pathways for PGE 2 synthesis and action are present in germ cells in the human fetal ovary, and PGE 2 can induce expression of genes known to be important in oocyte maturation and survival during the period when germ cells become associated with somatic cells to form follicles. Future studies are likely to identify roles for other PGs in both germ cell and somatic cell function.
